Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | Ras family GTPase | 0.0067 | 1 | 1 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0022 | 0.2597 | 0.2597 |
Trichomonas vaginalis | rheb, putative | 0.0067 | 1 | 1 |
Echinococcus granulosus | cyclins | 0.0022 | 0.2597 | 0.2597 |
Echinococcus granulosus | G2:mitotic specific cyclin B3 | 0.0022 | 0.2597 | 0.2597 |
Loa Loa (eye worm) | hypothetical protein | 0.0067 | 1 | 1 |
Giardia lamblia | Cyclin A | 0.0022 | 0.2597 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.2597 | 0.2597 |
Trichomonas vaginalis | ral, putative | 0.0067 | 1 | 1 |
Trypanosoma cruzi | CYC2-like cyclin, putative | 0.0022 | 0.2597 | 0.5 |
Echinococcus granulosus | ras gtpase | 0.0067 | 1 | 1 |
Echinococcus granulosus | cyclin B3 1 | 0.0022 | 0.2597 | 0.2597 |
Echinococcus granulosus | cyclin B | 0.0022 | 0.2597 | 0.2597 |
Echinococcus multilocularis | cyclins | 0.0022 | 0.2597 | 0.2597 |
Trichomonas vaginalis | rap1 and, putative | 0.0067 | 1 | 1 |
Trichomonas vaginalis | ras-dva small GTPase, putative | 0.0067 | 1 | 1 |
Echinococcus multilocularis | cyclin b3 | 0.0022 | 0.2597 | 0.2597 |
Schistosoma mansoni | cyclins | 0.0022 | 0.2597 | 1 |
Entamoeba histolytica | ras-1, putative | 0.0067 | 1 | 1 |
Echinococcus multilocularis | cyclins | 0.0022 | 0.2597 | 0.2597 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0022 | 0.2597 | 0.2597 |
Echinococcus granulosus | cyclins | 0.0022 | 0.2597 | 0.2597 |
Brugia malayi | Cyclin, N-terminal domain containing protein | 0.0022 | 0.2597 | 0.2597 |
Echinococcus multilocularis | cyclins | 0.0022 | 0.2597 | 0.2597 |
Leishmania major | CYC2-like cyclin, putative,cyclin 6, putative | 0.0022 | 0.2597 | 0.5 |
Echinococcus multilocularis | G2:mitotic specific cyclin B3 | 0.0022 | 0.2597 | 0.2597 |
Echinococcus granulosus | cyclins | 0.0022 | 0.2597 | 0.2597 |
Brugia malayi | Ras-related protein R-Ras2 | 0.0067 | 1 | 1 |
Schistosoma mansoni | cyclin B | 0.0022 | 0.2597 | 1 |
Echinococcus multilocularis | ras gtpase | 0.0067 | 1 | 1 |
Loa Loa (eye worm) | Ras protein let-60 | 0.0067 | 1 | 1 |
Echinococcus multilocularis | cyclin B | 0.0022 | 0.2597 | 0.2597 |
Echinococcus granulosus | cyclins | 0.0022 | 0.2597 | 0.2597 |
Plasmodium falciparum | cyclin | 0.0022 | 0.2597 | 0.5 |
Onchocerca volvulus | 0.0022 | 0.2597 | 1 | |
Loa Loa (eye worm) | cyclin domain-containing protein | 0.0022 | 0.2597 | 0.2597 |
Trichomonas vaginalis | GTP-binding protein rit, putative | 0.0067 | 1 | 1 |
Trypanosoma cruzi | cyclin 6, putative | 0.0022 | 0.2597 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.0022 | 0.2597 | 0.5 |
Echinococcus granulosus | cyclin b3 | 0.0022 | 0.2597 | 0.2597 |
Loa Loa (eye worm) | hypothetical protein | 0.0022 | 0.2597 | 0.2597 |
Echinococcus multilocularis | cyclin B3 1 | 0.0022 | 0.2597 | 0.2597 |
Entamoeba histolytica | Ras family GTPase | 0.0067 | 1 | 1 |
Giardia lamblia | G2/mitotic-specific cyclin B | 0.0022 | 0.2597 | 0.5 |
Echinococcus granulosus | cyclins | 0.0022 | 0.2597 | 0.2597 |
Schistosoma mansoni | cyclin B3 | 0.0022 | 0.2597 | 1 |
Echinococcus multilocularis | cyclins | 0.0022 | 0.2597 | 0.2597 |
Toxoplasma gondii | hypothetical protein | 0.0016 | 0.1744 | 0.5 |
Leishmania major | cyclin | 0.0022 | 0.2597 | 0.5 |
Trypanosoma brucei | mitotic cyclin 6 | 0.0022 | 0.2597 | 0.5 |
Trichomonas vaginalis | dexras1, putative | 0.0067 | 1 | 1 |
Echinococcus multilocularis | cyclins | 0.0022 | 0.2597 | 0.2597 |
Trypanosoma cruzi | cyclin, putative | 0.0022 | 0.2597 | 0.5 |
Trypanosoma cruzi | cyclin, putative | 0.0022 | 0.2597 | 0.5 |
Echinococcus multilocularis | cyclins | 0.0022 | 0.2597 | 0.2597 |
Echinococcus multilocularis | cyclins | 0.0022 | 0.2597 | 0.2597 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.